Skip to main content
Signal8

Khan Bilal Arshad

SEC insider (Form 3/4/5 filer). CIK 0002108044. Director at SpyGlass Pharma, Inc. (SGP). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 9, 2026. Located in ALISO VIEJO, CA.

Companies Khan Bilal Arshad has filed insider reports for

  • SpyGlass Pharma, Inc. (SGP): Director
Khan Bilal Arshad profile photo

Khan Bilal Arshad

CIK: 0002108044

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SpyGlass Pharma, Inc. logo
SGP

SpyGlass Pharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Purchase
    Direct
    20K shares at avg. $16.00$320K
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 9, 2026
    Purchase
    Indirect
    115K shares at avg. $16.00$1.8M
  • SpyGlass Pharma, Inc. logo
    SGP

    SpyGlass Pharma, Inc.

    Feb 5, 2026
    Award

    Stock Option (right to buy)

    Direct
    13.7K shares-

1-3 of 3